Ronald J. Mattson - Concepedia

Author

Ronald J. Mattson

Bristol-Myers Squibb (United States)

Also Known As

Ronald J Mattson, Ronald J. Mattson, Ronald Mattson

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)University of South Carolina Bristol-Myers Squibb (Germany)

About

Ronald J. Mattson is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	536
2	Biochemistry	9	9	246
3	Engineering	7	7	340
4	Natural Sciences	7	7	310
5	Social Sciences	3	3	95

Ronald J. Mattson

Publications

967

Citations

H-Index

Page 1

	Year	Citations
An improved method for reductive alkylation of amines using titanium(IV) isopropoxide and sodium cyanoborohydride Ronald J. Mattson, Kahnie M. Pham, David J. Leuck, The Journal of Organic Chemistry Improved MethodSodium CyanoborohydrideEngineeringChemical AnalysisAltmetric Attention Score	1990	185
Enantioselective Synthesis of a Highly Potent Selective Serotonin Reuptake Inhibitor. An Application of Imidazolidinone Catalysis to the Alkylation of Indoles with an α,β-Disubstituted α,β-Unsaturated Aldehyde Dalton King, Zhaoxing Meng, Derek J. Denhart, Organic Letters Asymmetric CatalysisMedicinal ChemistryEnantioselective SynthesisImidazolidinone Catalyst 3BNatural Sciences	2005	123
A Strategy to Minimize Reactive Metabolite Formation: Discovery of (<i>S</i>)-4-(1-Cyclopropyl-2-methoxyethyl)-6-[6-(difluoromethoxy)-2,5-dimethylpyridin-3-ylamino]-5-oxo-4,5-dihydropyrazine-2-carbonitrile as a Potent, Orally Bioavailable Corticotropin-Releasing Factor-1 Receptor Antagonist Richard A. Hartz, Vijay T. Ahuja, Xiaoliang Zhuo, Journal of Medicinal Chemistry Pharmaceutical ScienceMetabolic CharacterizationReceptor AntagonistPharmacotherapyPharmaceutical Chemistry	2009	54
[3H]5-carboxamidotryptamine labels multiple high affinity 5-HT1D-like sites in guinea pig brain Cathy D. Mahle, Henry P. Nowak, Ronald J. Mattson, European Journal of Pharmacology Molecular NeuroscienceNeuroanatomyMedicineNeuropharmacologyNeuroscience	1991	46
Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors Jeffrey A. Deskus, James R. Epperson, C.P. Sloan, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryFunctional SelectivityHomotryptamines 3Medicine	2007	40
Ortho-directed lithiation in .pi.-deficient diazinyl heterocycles Ronald J. Mattson, C.P. Sloan The Journal of Organic Chemistry AltmetricsMolecular SciencesEngineeringHeterocyclicDonut Icon	1990	40
In Vitro Intrinsic Clearance-Based Optimization of<i>N</i><sup>3</sup>-Phenylpyrazinones as Corticotropin-Releasing Factor-1 (CRF<sub>1</sub>) Receptor Antagonists Richard A. Hartz, Vijay T. Ahuja, Maria Rafalski, Journal of Medicinal Chemistry	2009	37
Catalytic Asymmetric Diazoacetate Cyclopropanation of 1-Tosyl-3-vinylindoles. A Route to Conformationally Restricted Homotryptamines Lawrence R. Marcin, Derek J. Denhart, Ronald J. Mattson Organic Letters Resulting CycloadductsDerivativesEngineeringBiochemistryHeterocyclic	2005	36
Conformationally Restricted Homotryptamines. 2. Indole Cyclopropylmethylamines as Selective Serotonin Reuptake Inhibitors Ronald J. Mattson, John D. Catt, Derek J. Denhart, Journal of Medicinal Chemistry Medicinal ChemistryPsychoactive DrugPotent Hsert BindingBiochemistryIndole Ring	2005	33
Synthesis, Structure−Activity Relationships, and In Vivo Evaluation of<i>N</i><sup>3</sup>-Phenylpyrazinones as Novel Corticotropin-Releasing Factor-1 (CRF<sub>1</sub>) Receptor Antagonists Richard A. Hartz, Vijay T. Ahuja, Argyrios G. Arvanitis, Journal of Medicinal Chemistry	2009	32

Page 1